Thomas P. Kanyok

A Phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis.

Roxana Rustomjee, Christian Lienhardt, Thomas P. Kanyok et al. · PubMed · 2008 · 284 citations

Public Health, Infectious Diseases, Pharmacology +17

Randomised controlled trial of aminosidine (paromomycin) v sodium stibogluconate for treating visceral leishmaniasis in North Bihar, India   Commentary: Some good news for treatment of visceral leishmaniasis in Bihar

T. K. Jha, Piero Olliaro, C.P. Thakur et al. · BMJ · 1998 · 170 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Comparison of chlorproguanil-dapsone with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in young African children: double-blind randomised controlled trial

Ali Alloueche, W. S. Bailey, Sarah Barton et al. · The Lancet · 2004 · 107 citations

Medicine, Pharmacology, Pharmacotherapy +14

A prospective randomized, comparative, open-label trial of the safety and efficacy of paromomycin (aminosidine) plus sodium stibogluconate versus sodium stibogluconate alone for the treatment of visceral leishmaniasis

C.P. Thakur, Thomas P. Kanyok, Avinash Pandey et al. · Transactions of the Royal Society of Tropical Medicine and Hygiene · 2000 · 105 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Treatment of visceral leishmaniasis with injectable paromomycin (aminosidine). An open-label randomized phase-II clinical study

C.P. Thakur, Thomas P. Kanyok, Avinash Pandey et al. · Transactions of the Royal Society of Tropical Medicine and Hygiene · 2000 · 68 citations

Pharmacy, Infectious Diseases, Pharmacology +17